Horny Goat Weed (Epimedium) for Bone Health

Research suggests that icariin and icaritin, the primary bioactive compounds derived from Epimedium, demonstrate consistent bone-protective effects across a substantial body of preclinical literature, with proposed mechanisms including stimulation of osteoblast differentiation and mineralization, inhibition of osteoclast-mediated bone resorption, modulation of signaling pathways such as ER-PI3K/Akt and NLRP3, and more recently described effects involving the gut-bone axis and extracellular nanovesicle activity. Studies indicate this evidence base is composed predominantly of animal studies, cell-based experiments, and narrative reviews, with at least one 2018 review noting some clinical trial data for postmenopausal osteoporosis prevention, though large-scale, well-controlled human trials remain limited in number. The overall direction across all 19 studies reviewed here is supportive, with no contradictory findings represented in this set, which may reflect a degree of publication bias and should be interpreted with caution. Readers should be aware that the gap between promising preclinical results and confirmed clinical efficacy in humans has not yet been fully bridged, and further robust clinical research would be needed to draw firm conclusions about real-world benefit.